SST-0225

DRUG2 trials

Sponsors

Strategic Science & Technologies, LLC

Conditions

Delayed Onset Muscle SorenessDelayed Onset Muscle Soreness, DOMS

Phase 2

Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness

CompletedNCT02339129

Strategic Science & Technologies, LLCDelayed Onset Muscle Soreness

Start: 2014-11-30End: 2015-03-31Updated: 2016-09-09

Phase 3

Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)

CompletedNCT02597634

Strategic Science & Technologies, LLCDelayed Onset Muscle Soreness, DOMS

Start: 2015-11-30End: 2016-10-31Updated: 2016-10-13